Kelly Hallowell
kelhall.bsky.social
Kelly Hallowell
@kelhall.bsky.social
University of Minnesota infectious diseases fellow 🦠 | Ask me what I'm reading (in addition to Uptodate and journal articles) 📚 | #IDSky #MedEd
I've been working on a quality improvement project teaching internal medicine residents about HIV PrEP prescribing. A sneak peak at one of many infographics I've made so far using the skills I learned from the ID Digital Institute @febrilepodcast.com! #IDSky
October 8, 2025 at 5:58 PM
Exciting to see guidelines with a simplification of classifications as well as discussion of the importance of both patient and local resistance patterns!
🚨 IDSA has released the first guidelines for the management and treatment of complicated urinary tract infections (cUTIs)!

The new guidelines simplify the prior definitions of uncomplicated UTIs and cUTIs, & address treatment for cUTIs.

View guidelines: bit.ly/4lUjN1a
July 18, 2025 at 6:45 PM
Perhaps a small piece of hopeful news? There is no benefit to a highly effective drugs if we can't get it to the people who need it.
Gilead Expands Global Access to Lenacapavir With New HIV Prevention Partnership
Gilead Sciences has partnered with the Global Fund to supply up to 2 million doses of its long-acting HIV prevention drug, lenacapavir, to low and lower-middle income countries.
www.contagionlive.com
July 11, 2025 at 12:03 AM
New to this space! I'm an adult infectious diseases fellow interested in STIs and medical education. Here to learn all your clinical pearls and maybe a share a few of my own.
May 30, 2025 at 6:49 PM